Literature DB >> 999792

Conformational flexibility of the serum amyloid precursor SAA.

J D Sipe, K P McAdam, B F Torain, G G Glenner.   

Abstract

SAA is a normal acute-phase serum protein and is thought to be the precursor of amyloid protein AA which is deposited as insoluble beta-pleated sheet fibrils in secondary amyloidosis. Native SAA has a molecular weight of 160,000 and has not been isolated; it has been most frequently purified as a species (designated SAAL) of 12,500 mol. wt. by gel filtration in dissociating solutions. The conformational properties of SAA proteins in patients with and without amyloidosis have been compared in an effort to determine the factors involved in the induction of the beta-pleated sheet conformation in the amyloid SAA protein prior to fibril deposition. Amyloid and nonamyloid SAA proteins are similar in that they readily undergo conformational changes which result in the formation of heterogenous mol. wt. SAA species and in an increased exposure of antigenic determinants which cross-react with AA fibril proteins. Amyloid and nonamyloid SAA are different, however, in that amyloid SAA is more resistant to dissociation to SAAL. Amyloid SAAL, while similar to nonamyloid SAAL in immunoreactivity, shows a greater tendency toward aggregation. The relative resistance of both amyloid SAA and SAAL to complete dissociation may play an important role in amyloid fibril formation from these precursors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999792      PMCID: PMC2041229     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  22 in total

1.  The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences.

Authors:  E P. Benditt; N Eriksen; M A. Hermodson; L H. Ericsson
Journal:  FEBS Lett       Date:  1971-12-01       Impact factor: 4.124

2.  Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay.

Authors:  J D Sipe; T F Ignaczak; P S Pollock; G G Glenner
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  The genesis of apudamyloid in endocrine polypeptide tumours: histochemical distinction from immunamyloid.

Authors:  A G Pearse; S W Ewen; J M Polak
Journal:  Virchows Arch B Cell Pathol       Date:  1972

5.  Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils.

Authors:  G G Glenner; E D Eanes; H A Bladen; R P Linke; J D Termine
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

Review 6.  Amyloidosis: its nature and pathogenesis.

Authors:  G G Glenner; W D Terry; C Isersky
Journal:  Semin Hematol       Date:  1973-01       Impact factor: 3.851

7.  Murine amyloidosis: immunologic characterization of amyloid fibril protein.

Authors:  C Isersky; D L Page; P Cuatrecasas; R A DeLellis; G G Glenner
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

8.  Isolation and partial characterization of SAA-an amyloid-related protein from human serum.

Authors:  C J Rosenthal; E C Franklin; B Frangione; J Greenspan
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

9.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

10.  Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils.

Authors:  M Skinner; E S Cathcart; A S Cohen; M D Benson
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  4 in total

1.  Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein.

Authors:  E P Benditt; N Eriksen; R H Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

2.  Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation.

Authors:  K P McAdam; R J Elin; J D Sipe; S M Wolff
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

3.  Induction of the acute-phase serum protein SAA requires both RNA and protein synthesis.

Authors:  J D Sipe
Journal:  Br J Exp Pathol       Date:  1978-06

4.  Levels of the serum amyloid A protein (SAA) in normal persons of different age groups.

Authors:  W Hijmans; J D Sipe
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.